The quest for universal health coverage: achieving social protection for all in Mexico by Knaul, Felicia Marie et al.
Western University
Scholarship@Western
Aboriginal Policy Research Consortium International (APRCi)
8-16-2012
The quest for universal health coverage: achieving
social protection for all in Mexico
Felicia Marie Knaul
Eduardo González-Pier
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Lloréns, Mariana; Sandoval,, Rosa; Caballero, Francisco; Hernández-Avila, Mauricio; Juan, Mercedes; Kershenobich, David; Nigenda,
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The quest for universal health coverage: achieving social 
protection for all in Mexico
Felicia Marie Knaul, Eduardo González-Pier, Octavio Gómez-Dantés, David García-Junco, Héctor Arreola-Ornelas, Mariana Barraza-Lloréns, 
Rosa Sandoval, Francisco Caballero, Mauricio Hernández-Avila, Mercedes Juan, David Kershenobich, Gustavo Nigenda, Enrique Ruelas, 
Jaime Sepúlveda, Roberto Tapia, Guillermo Soberón, Salomón Chertorivski*, Julio Frenk*
Mexico is reaching universal health coverage in 2012. A national health insurance programme called Seguro Popular, 
introduced in 2003, is providing access to a package of comprehensive health services with ﬁ nancial protection for more 
than 50 million Mexicans previously excluded from insurance. Universal coverage in Mexico is synonymous with social 
protection of health. This report analyses the road to universal coverage along three dimensions of protection: against 
health risks, for patients through quality assurance of health care, and against the ﬁ nancial consequences of disease and 
injury. We present a conceptual discussion of the transition from labour-based social security to social protection of 
health, which implies access to eﬀ ective health care as a universal right based on citizenship, the ethical basis of the 
Mexican reform. We discuss the conditions that prompted the reform, as well as its design and inception, and we describe 
the 9-year, evidence-driven implementation process, including updates and improvements to the original programme. 
The core of the report concentrates on the eﬀ ects and impacts of the reform, based on analysis of all published and 
publically available scientiﬁ c literature and new data. Evidence indicates that Seguro Popular is improving access to health 
services and reducing the prevalence of catastrophic and impoverishing health expenditures, e specially for the poor. 
Recent studies also show improvement in eﬀ ective coverage. This research then addresses persistent challenges, 
including the need to translate ﬁ nancial resources into more eﬀ ective, equitable and responsive health services. A next 
generation of reforms will be required and these include systemic measures to complete the reorganisation of the health 
system by functions. The paper concludes with a discussion of the implications of the Mexican quest to achieve universal 
health coverage and its relevance for other low-income and middle-income countries.
Introduction
A central topic in the global agenda is universal health 
coverage. WHO has deﬁ ned universal coverage as access 
of all people to comprehensive health services at 
aﬀ ordable cost and without ﬁ nancial hardship through 
protection against catastrophic health expenditures.1
Universal health coverage is a quest with three stages: 
(1) universal enrolment, a term closely associated with 
legal coverage, entitles all people to beneﬁ t from 
health services funded by publicly organised insurance; 
(2) coverage that is universal implies regular access to a 
comprehensive package of health services with ﬁ nancial 
protection for all; and (3) universal eﬀ ective coverage 
guarantees to all on an equal basis, the maximum 
attainable health results from an appropriate package of 
high-quality services that also prevents ﬁ nancial shocks 
by reducing out-of-pocket payments.2,3
These stages tend to be progressive but with an 
important degree of overlap. As enrolment proceeds to 
include the entire population, the package of covered 
health services expands, thus increasing the level of 
ﬁ nancial protection. Simultaneously, quality improves as 
the system adjusts to meet new demands. In fact, the 
2010 World Health Report highlights the tradeoﬀ s 
between three essential dimen sions of universality of 
coverage: who (enrolment), which services, and what 
proportion of direct costs (ﬁ nancial protection).1
Mexico has advanced signiﬁ cantly in the quest for 
universal coverage—particularly on the ﬁ rst two stages—
as a result of the 2003 health reform that legislated the 
System of Social Protection in Health (SSPH) and 
Constitutional reform implemented in 1983. The third 
stage is a continuous challenge. As for all countries, 
quality of care is a moving target for Mexico. 
In 2012, after 9 years of implementation, the country 
reached a major milestone in universal coverage. As of 
April, 52·6 million Mexicans, previously uninsured, 
were incorporated into the SSPH and the budgetary 
allocation for universal coverage was achieved.4 The 
implementation experience is relevant for other countries 
undergoing similar reforms.
The most prominent component of SSPH is Seguro 
Popular. This public insurance scheme oﬀ ers universal 
access to a comprehensive package of personal health 
services with ﬁ nancial protection, thus guaranteeing the 
eﬀ ective exercise of the right to health protection. This 
right is recognised in the Mexican Constitution of 1983, 
yet had been denied to the majority of the population.
The vision of the reform was to reorganise the health 
system by functions, improve equity and eﬃ  ciency, and 
achieve eﬀ ective universal coverage. The stewardship 
function is the ultimate responsibility of a strengthened 
Ministry of Health. Financing is done by a new 
public insurance scheme that supersedes the existing 
employment-based social insurance mechanisms limited 
to salaried workers. Lastly, services are delivered by a 
plurality of accredited providers, public and private.5–7 
This vision has been partly implemented, yet continuous 
challenges point to the need for new reforms.
The initial steps of the reform were discussed in a 
2006 Lancet Series.8–14 With only 3 years of experience, 
this Series focused on the initial challenges and lessons 
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of broad reform. Since then, implementation across 
two governmental administrations has produced 
substantial advances in the pursuit of universal 
coverage. At the same time, expansions in enrolment 
and covered services exposed unforseen hurdles and 
unmet needs.
This report analyses the road to universal health 
coverage in Mexico, including present challenges, future 
policy proposals, and worldwide implications. The ﬁ rst 
part is a conceptual discussion of the transition from 
labour-market-based social security, to social protection 
of health, the universal right of access to eﬀ ective health 
care based on the sole requirement of citizenship for 
inclusion.2 Part two describes the design and initial phase 
of the health reform in Mexico, the creation of the SSPH, 
and the conditions that prompted the reform. Part three 
describes the implementation process with a focus on 
how evidence prompted policy dynamism, and hence 
improvements on the initial reform design. Part four 
concentrates on the eﬀ ects of the reform, on the basis of 
the analysis of all published and publicly available 
documentation on Seguro Popular. Part ﬁ ve addresses the 
successes and challenges of implemen tation of SSPH. 
The next section discusses the future generation of 
reforms—the measures needed to reorganise by func-
tions and better integrate the major institutional 
segments of the Mexican health system to increase 
eﬃ  ciency and guarantee universal access and egalitarian 
exercise of the right to social protection of health. This 
report concludes with a discussion of lessons learned 
from the Mexican quest to achieve universal coverage 
and their worldwide relevance.
Universal health coverage and social protection 
of health
If health is to be a truly universal right, it is essential to 
decouple access to insurance from formal, salaried 
employment, and to adopt a comprehensive notion of 
social protection of health. A comprehensive approach has 
three major dimensions: (1) protection against health risks 
through surveillance, preventive, and regulatory activities; 
(2) protection of patients through quality assurance of 
health care; (3) and ﬁ nancial protection against the 
economic consequences of disease and injury.15,16
The essential responsibility of the State is the protection 
of its citizens against threats or downside risk: natural 
disasters, environmental degradation, insecurity, and 
violations of the physical integrity and rights of 
individuals.17 This encompasses physical, environmental, 
legal, and civil protection.
Social protection is an additional dimension of this 
essential responsibility, which the International Labour 
Oﬃ  ce deﬁ nes as “the protection which society provides 
for its members through a series of public measures”.18 
The ultimate purpose of social protection is to expand 
human capabilities, which allow citizens to fully enjoy 
their economic, social, and cultural rights.19 Expansion of 
these capabilities increases the freedom of individuals, 
strengthens social cohesion, and promotes overall indi-
vidual and population-wide wellbeing.20
Yet, in many countries, the right to health care is an 
employment beneﬁ t, restricted to the salaried workforce. 
Although traditional social security is a major component 
of social protection and provides access to health care and 
other programmes aimed at protecting family income, 
access is restricted. Thus, con ceiving social protection as 
an employment beneﬁ t has major limitations both in 
terms of attainment of universal coverage and for 
expansion of other social beneﬁ ts. These limitations are 
particularly severe in countries where a large share of the 
population are non-salaried, independent workers or do 
not participate in the labour market.21
A growing global movement for universal coverage is 
advocating for the transformation of health care into 
a universal right, which entails a transition from 
traditional social insurance as an employment beneﬁ t to 
universal social protection of health, a right of citizenship. 
Translation of this social right into practice implies a 
continuous strengthening of health systems to enable 
them to oﬀ er eﬀ ective universal coverage.
In Mexico, institutional transformation was enabled by 
establishing the SSPH through health reform. Universal 
health coverage is synonymous with universal social 
protection of health and includes a comprehensive 
package of personal and non-personal health services 
spanning promotion, prevention, treatment, and re-
habilitation. Social protection is distinguished from 
traditional employment-based social security because it 
is not dependent on labour market participation.
The Mexican health reform: design and 
execution
The 2003 reform established a system encompassing 
all three dimensions—risk, patient, and ﬁ nance—
embedded in the concept of social protection of health. 
Speciﬁ cally, public health interventions, institutions and 
dedicated ﬁ nancing are providing protection against Figure 1: Dimensions of social protection in health
Dimension
Protection
against 
health risk
• Epidemiological
   surveillance
• Health promotion
• Disease prevention
• Risk mitigation
• New public health agency
• Health card scheme with gender
   and life-course perspective
• Fund for community health services
• Quality of care
   assurance:
 • Safety
 • Eﬀectiveness
 • Responsiveness
• National Crusade for 
Health Quality
• Comprehensive
   health insurance
• Seguro Popular:
 • Fund for essential health services
 • Fund for protection against
  catastrophic health expenditures
Patient
protection
Social
protection
in health
Financial
protection
Main actions Policy instruments of the
Mexican Reform
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health risks; system-wide initiatives that enhance patient 
safety, eﬀ ectiveness, and responsiveness are protecting 
the quality of health care; and Seguro Popular is continually 
expanding protection against the ﬁ nancial shocks of 
disease and disability (ﬁ gure 1).
Origins and precursors of the reform
Until the beginning of the present century, the Mexican 
health system, like most in Latin America, was seg-
mented and unequal.22 Table 1 and panel 1 describe the 
basic characteristics of Mexico and its health system. 
The insured population received health care from 
well ﬁ nanced, vertically-integrated, federal institutions, 
whereas the uninsured relied on underfunded, state-
decentralised institutions.25 Every public institution was 
responsible for stewardship, ﬁ nancing, and service 
delivery only for its particular population. At the same 
time, many families relied on the poorly regulated, costly 
private sector. Households—even those with social 
security—paid for a substantial proportion of their health 
care directly, at point of service and out of pocket, 
exposing families to impoverishing expend itures.26
As is the case in many countries, regular access to 
health care with ﬁ nancial protection was oﬀ ered only to 
salaried workers and their families, through social 
security mechanisms. The wealthier, formal private 
sector received care from the Mexican Institute for Social 
Security (IMSS) and the federal public workers from the 
Institute for Social Security and Services for Civil 
Servants (ISSSTE).26
The non-salaried population (self-employed workers, 
the underemployed, the unemployed, those out of the 
labour market permanently or temporarily along with 
their families) typically accessed health services through 
the state Ministry of Health on a public assistance basis. 
Health care for this population was funded from 
uncertain, residual budget allocations that did not have 
explicit entitlements. Care was not comprehensive, and 
families paid out-of-pocket, especially for basic services 
and medicines.
The decentralisation of services by the federal Ministry 
of Health—between 1985 and 2000—devolved to the 
states the responsibility of health service delivery for the 
uninsured population. However, rules to guide the 
2000 2004 2008 2010
Demographic
Total population (millions) 98·4 103·0 106·7 112·3
Population aged younger than 5 years (% of total) 11·6% 10·5% 9·8% 9·4%
Population aged 65 years or older (% of total) 4·7% 5·1% 5·6% 6·2%
Life expectancy at birth (years) 74·0 74·5 75·1 75·4
Fertility rate (livebirths per woman) 2·4 2·2 2·1 2·1
Population residing in rural areas (%)* 25·2% 23·7% 21·9% 23·2%
Socioeconomic
GDP per capita, PPP (constant 2005 international $)† 11 852·7 11 959·3 12 892·8 12 440·9
GDP annual growth (%)‡ 6·6% 4·1% 1·2% 5·5%
Gini index§ 51·9 46·1 48·3 50·9
Poverty headcount ratio at national poverty line (% of population)¶ 53·6% 47·2% 47·7% 51·3%
Poverty headcount ratio at $2 per day (PPP; % of population) 15·1% 7·6% 5·2% 5·7%
Labour force participation rate (% of population aged 15 years or older)|| 60·3% 60·6% 61·8% 61·7%
Primary education completion rate, total (% of relevant age group)** 98·0% 99·0% 104·0% NA
Health
Infant mortality (rate per 1000 livebirths) 18·2 17·6 15·2 14·1
Mortality of children younger than 5 years (deaths per 1000 livebirths) 28·5 20·5 17·9 16·8
Communicable disease, maternal, perinatal, and nutrition associated mortality (%) 15·4 13·4 11·6 10·8
Non-communicable disease mortality (%) 70·7 73·8 75·3 74·8
Contraceptive prevalence rate (% of women aged 15–49 years)†† 70·0 73·0 72·5 NA
GDP=gross domestic product. PPP=purchasing power parity. NA=not available. *Population in localities with less than 2500 inhabitants. †GDP converted to international 
dollars using PPP rates. ‡Annual percentage growth rate of GDP at market prices based on constant local currency. Aggregates are based on constant US$2000. §Measures 
the extent to which the distribution of income or consumption expenditure in individuals or households within an economy deviates from a perfectly equal distribution. 
A Gini index of 0 represents perfect equality, whereas an index of 100 implies perfect inequality. ¶Poverty rate measured as the percentage of the population living under the 
national patrimony threshold as deﬁ ned by the National Council for the Evaluation of Social Development Policy (CONEVAL). CONEVAL deﬁ nes patrimony poverty as 
“insuﬃ  ciency of the income available to acquire the food basket, as well as to make the necessary expenses in health, clothes, housing, transport and education, even if the 
entire household’s income was used exclusively for the acquisition of these goods and services”. ||Labour force participation rate is the proportion of the population 
aged 15 years and older that is economically active. **Number of new entrants in the last grade of primary education, regardless of age, expressed as percentage of the total 
population of the theoretical entrance age to the last grade of primary. This indicator is also known as gross intake rate to the last grade of primary. The ratio can exceed 100% 
because of overaged and underaged children who enter primary school late or early, or repeat grades. ††Contraceptive prevalence rate is the percentage of women who are 
practising, or whose sexual partners are practising, any form of contraception and is measured for married women ages 15–49 years only. See appendix for data sources.
Table 1: Basic demographic, socioeconomic, and health characteristics, Mexico, 2000–10
See Online for appendix
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allocation of federal resources, state ﬁ nancial contri-
butions, and state out-of-pocket fees for services provided, 
were missing.27
In 1997, IMSS underwent ﬁ nancial reform of health 
and pensions.28,29 A key tenet was to decrease payroll 
contributions and increase reliance on general taxes, 
largely to reduce informality. An unintended conse-
quence was increased inequity in the federal allocation 
to health care because general tax funds, levied on 
all Mexicans, were directed towards the salaried 
labour force.
A decade of evidence inspired the Ministry of Health to 
focus on the ﬁ nancial aspects of reform. In the early 
1990s, the ﬁ rst national health accounts provided 
surprising results: more than 50% of health expenditure 
was out of pocket. This result showed overreliance on 
ineﬃ  cient, inequitable, point-of-service funding that 
exposed Mexican households, especially the poor and 
uninsured, to catastrophic and impoverishing health 
expenditures.25,30–32 As a result, Mexico performed poorly 
on the fairness of ﬁ nancial contribution index of the 
World Health Report 2000.33
Although high catastrophic expenditure portrayed 
the exclusion of the poor from prepaid insurance and 
ﬁ nancial protection, families of all income levels, including 
those with social security, searched for in creased access to 
high-quality care. Thus, out-of-pocket was a function of 
implicit service rationing through waiting times, medical 
drug-shortages, incomplete access to the package of 
covered services, and poor quality of care.5 Ironically and 
unfortunately, a large part of this spending went to low 
quality, unregulated private providers.
In sum, the 2003 reform was largely motivated by 
imbalances that necessitated ﬁ nancial har monisation 
across public providers. Further, the system before 
2003 was characterised by low general health spending; 
predominance of private, out-of-pocket spending; unfair 
allocation of public resources between the insured and 
uninsured, and among states; inequitable state contri-
butions to health ﬁ nancing, and underinvestment in 
equipment and infrastructure.9 These imbalances, typical 
of many low-income and middle-income countries, pre-
vented the health system from responding to the 
challenges of ageing and the predominance of costly, 
chronic disease and injury.
The creation of the SSPH implied a major legislative 
reform focused on ﬁ nancial reorganisation to correct 
these imbalances. The law, approved by a large majority 
of Congress in April 2003, came into eﬀ ect in 2004.9,34
The overall goal of the 2003 reform was to achieve 
universal coverage by including the more than 50 million 
Mexicans who had previously been excluded from public, 
social insurance. The goal of universal coverage was 
grounded in the commitment to increase funding for 
health by one percentage point of gross domestic product 
(GDP), mainly through public resources. The General 
Health Law established a transition period to 2011, later 
extended to 2012, to help with a gradual aﬃ  liation process 
and capacity-building to absorb add itional resources. 
Seguro Popular guaranteed legislated access to an explicit 
and comprehensive package of essential services, as well 
as more costly, specialised interventions associated with 
speciﬁ c diseases and health conditions.
Innovations to promote protection for patients and 
against health risks
The ﬁ nancial reform was complemented with supply-
strengthening provisions, including hospital manage-
ment reform, improved schemes for drug supply, 
outcome-oriented information systems, a master plan for 
long-run investment in health infrastructure, and 
technology assessment.
Emphasis was also placed on public health through 
the following instruments: (1) a protected fund for 
community services; (2) a set of personal health pro-
motion and disease prevention guides (similar to the 
traditional immunisation certiﬁ cates) with a gender and 
life course perspective; (3) a comprehensive reorganisation 
of regulatory activities through a new public health 
agency—the Federal Commission for the Protection 
against Health Risks (COFEPRIS) charged with safety 
and eﬃ  cacy approvals of new drugs and medical devices, 
food safety regulations, enforcement of environmental 
and occupational health standards, and control of 
marketing of hazardous substances such as alcohol and 
tobacco; and (4) major investments in public health to 
enhance security through epidemiological surveillance 
and improved preparedness to respond to emergencies, 
natural disasters, pandemics, and bioterrorism.35
Panel 1: Overview of Mexico, 2000–10
The population of Mexico grew from 98 million to 112 million between 2000 and 2010. 
In view of the process of demographic transition, fertility decreased and reached near 
replacement levels, the proportion of the population aged 5 years or younger fell below 
10%, and the elderly population grew from 4·7% to 6·2%.
Overall, health indicators improved steadily throughout the decade. Life expectancy rose 
to more than 75 years of age, infant mortality fell from 18·2 to 14·1 deaths per 1000 
livebirths, and mortality in children under 5 years old fell from 28·5 to 16·8 deaths per 
1000 livebirths.
Mexico has gone through a rapid, polarised, and protracted epidemiological transition.23 The 
health burden has shifted towards non-communicable disease and injury that represented 
less than a third of mortality in 1950, to 85% in 2000, and to almost 90% in 2010.
Despite the economic crisis of the last part of the decade, gross domestic product (GDP) 
per capita grew 5% in real terms. In 2008, the growth rate fell to 1·2% and was negative in 
2009 (–6·2%). The proportion of the population living in poverty declined between 
2000 and 2010. Still, during interim periods of crisis, poverty increased. The Gini 
coeﬃ  cient similarly improved and then worsened with the crisis.
Recovery from the crisis has been impressive.24 In 2010, GDP growth was up to 5·5% and 
reached 3·9% by 2011.
Please see table 1 for basic demographic, socioeconomic, and health characteristics of Mexico, 2000–10.
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The creation of COFEPRIS was key to strengthening 
the stewardship role of the Ministry of Health. One 
example is the design and implementation of tobacco-
control measures, including a ban on mass media 
advertising, the creation of a General Law on Tobacco 
Control and increased tobacco prices. The investments in 
epidemiological surveillance, state laboratories and 
preparedness were crucial in confronting the 2009 H1N1 
inﬂ uenza crisis.36,37
Another crucial element to strengthen stewardship was 
the expansion of the role of the General Health Council 
(Consejo de Salubridad General), a collective decision-
making body that spans all participants in the health 
sector and whose leadership requires Presidential 
appointment. The Council was charged with deﬁ ning 
and updating the package of covered high-cost inter-
ventions, certiﬁ cation of health-care providers, and more 
recently, with the design of strategies to prevent non-
communicable disease.38
To reinforce patient protection, the central programme 
of the managerial reform was the National Crusade for 
Quality in Health Care. The purpose of this programme 
was to enhance patient safety, improve responsiveness, 
manage facility accreditation and provider certiﬁ cation, 
implement quality improvement initiatives, measure 
technical and interpersonal quality, and undertake 
performance benchmarking among states and other 
organisations.39
Another important innovation was the creation of 
the National Center for Health Technology Excellence 
(CENETEC) in 2004. This Centre produces information 
and enables an evidence-based approach for invest-
ment and use of medical technologies, and coordinates 
the development of clinical practice guidelines. It has 
achieved international recognition and is a WHO 
collaborating centre.
Innovations to promote ﬁ nancial protection
Key to the ﬁ nancial innovations introduced by the SSPH 
is the separation of funding between personal health 
services and health-related public goods (including non-
personal health services).40 The separation is designed to 
protect public health services, which tend to be at risk in 
reforms that expand insurance.41
Funds are aggregated over the population without 
access to social security and divided into four com-
ponents: (1) stewardship, information, research, and 
development; (2) community health services; (3) essen-
tial personal or clinical health services; and (4) high-cost, 
catastrophic health interventions (table 2).
The regular budget of the Ministry of Health ﬁ nances 
stewardship functions, research, dissemin ation of infor-
mation, and human resource development. The Fund for 
Community Health Services covers health promotion, 
immunisation campaigns, primary preven tion, early 
detection, epidemiological surveillance, and control and 
risk protection activities. To avoid erosion of funding as 
reform proceeds, the services covered are explicitly 
deﬁ ned and expand from year-to-year, although funding 
is subject to annual budgetary negotiation.
Funding for personal or clinical services, by contrast, is 
based on a public insurance logic focusing on risk pooling, 
prepaid contributions according to capacity to pay, 
progressive subsidies provided through public funding 
from general taxation, and explicit entitlement to a package 
of health interventions.21 The instrument devised by the 
reform to ﬁ nance these services is the Seguro Popular.
Explicit entitlement to a package of speciﬁ c services is a 
milestone. The ﬁ nancial resources behind the insurance 
scheme are divided between a package of essential 
interventions provided in ambulatory settings and 
general hospitals ﬁ nanced through the Fund for Personal 
Health Services (FPHS), and a package of high-cost, 
specialised interventions that are available only through 
specialised providers and ﬁ nanced through the Fund for 
Protection against Catastrophic Health Expenditures 
(FPCHE; panel 2).10 More recently, a set of interventions 
speciﬁ cally addressing children and newborn babies, 
including new vaccines, were added through the Medical 
Insurance for a New Generation (Seguro Médico para una 
Nueva Generación).
Diﬀ erences in health or socioeconomic status are 
not taken into consideration and pre-existing condition 
clauses are forbidden in the enrolment process. This 
eliminates risk selection based on health needs. As 
stipulated by law, the essential and high-cost intervention 
packages must be progressively expanded.45 As funding 
increased, it became possible to combine horizontal 
coverage of a growing number of beneﬁ ciaries with vertical 
expansion of the interventions and entitlements (ﬁ gure 2).
The ﬁ nancial architecture of Seguro Popular was 
designed to increase equity in the application of federal 
funds between populations with and without social 
security. It was harmonised with the IMSS, guided by 
the 1997 reform.46 In 2007, the ISSSTE was also 
reformed and restructured along similar lines. As a 
result, allo cations are similar across all three agencies, 
paving the way for the creation of a single health fund 
and payer scheme.
Fund
Public goods
Stewardship Regular budget of the Ministry of Health
Information, research, and human resource development Regular budget of the Ministry of Health
Community health services Fund for Community Health Services
Personal health services
Essential health-care services (Seguro Popular) Fund for Personal Health Services
Health-care services for children and newborns Medical Insurance for a New Generation*
Specialised and high-cost services Fund for Protection against Catastrophic 
Health Expenditure
Adapted from Frenk J and colleagues.9 See appendix for data sources. *As of December, 2006.
Table 2: Funds of the System for Social Protection in Health by type of health good
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Like IMSS and ISSSTE, Seguro Popular ﬁ nancing is 
tripartite. In the absence of an employer, ﬁ nancial co-
responsibility is between the federal and state govern-
ments. A social contribution is provided by the federal 
gov ernment and was just under US$70 (MXN847) in 
2011. The federal and state governments each provide 
a solidarity contribution. On average, the federal 
solidarity contribution is 1·5 times, whereas the man-
dated state contribution is 50%, of the social contri-
bution per enrollee. In principal, the aﬃ  liate also 
contributes as a function of income. The law exempts 
low-income households—originally the two poorest 
and later the four poorest income deciles as well as 
families in deciles IV–VII that include a pregnant 
woman or a young child.
Funding for states is demand-driven as it is determined 
largely by Seguro Popular enrolment. The federal 
contribution is allotted to states by use of a formula based 
on enrolled individuals, health needs, and performance. 
The legally-mandated formula was a major innovation 
over previous inertial, subjective budgeting that was 
often driven by political negotiations.
Enrolment of most hard-to-reach, poorer segments of 
the population in both rural and urban areas was helped 
by the existence of Oportunidades, a large-scale social 
programme based on conditional cash transfers.8 
Oportunidades, initiated in 1997, now covers 5·8 million 
families—most of the poor.47 Further, states have 
the incentive to enrol the entire population to expand 
their budget.
Implementation of the Mexican health reform
Health system reforms are not linear processes. As has 
been the case in Mexico, continuous evidence-based 
policy reformulation stimulates and guides imple-
mentation. For example, MING, launched in December, 
2006, was a focal programme of the Government of 
President Felipe Calderón and an endorsement of Seguro 
Popular. MING provided an eﬀ ective, as well as politically 
salient, instrument to grow the SSPH.
MING wove new opportunities into the tapestry of 
covered beneﬁ ts and beneﬁ ciaries as an important 
complement to FPCHE and Seguro Popular. Whereas the 
FPCHE was based on accelerated coverage for speciﬁ c 
diseases and interventions, and the Seguro Popular was a 
gradual horizontal expansion of coverage by population 
group, MING used both platforms in a diagonal approach.
MING brought additional funding that allowed for the 
expansion of the catastrophic fund for newborn babies 
and children younger than 5 years, and accelerated 
coverage of Seguro Popular for their families. In 2007, 
110 interventions for newborn babies were added. As of 
2012, the programme covers 131 additional interventions 
and has grown six times to cover 5·95 million children 
(ﬁ gure 2). MING has been reinforced by targeted 
education and awareness-building on issues such as 
breast feeding and early childhood stimulation. Funding 
provided by MING was essential for the universalisation 
of rotavirus and Pneumococcal conjugate vaccines.
Another critical update was the reformulation of the 
Seguro Popular reimbursement unit from the family to 
the individual. Until 2010, the deﬁ nition of the family 
unit included the head of the household, the spouse or 
partner, dependent children (younger than 18 years, 
studying, or disabled), and parents older than 64 years. 
This deﬁ nition of the family unit allowed for the 
registration of individuals older than 18 years within the 
same household as single-person family units. Evidence 
showed a larger than expected number of single-person 
and small families being enrolled.48 In some cases, 
gaming by states split families living in the same 
household to increase enrollees and consequently the 
transfer of federal resources, putting at risk the overall 
ﬁ nancial health of the Seguro Popular.
At the same time, ﬁ nancing for the reform was 
calculated on the basis of an average nuclear family size 
of 4·3 members, which did not capture continuous 
declines or variance in family size across states. As a 
result, the allocation per person was larger for wealthier 
states where the average family size is smaller than in 
poorer states, contributing to inequities.49
The ﬁ nancing unit was redeﬁ ned in 2010 through a 
modiﬁ cation of the General Health Law from a family to a 
capitation fee per enrolled individual. Under the revised 
Panel 2: Financial coverage and service delivery of catastrophic interventions
The System of Social Protection in Health (SSPH) covers costly, specialised interventions 
through the Fund for Protection against Catastrophic Health Expenditures (FPCHE) using 
8% of all resources annually allocated to Seguro Popular, which can be supplemented 
through earmarked contributions. These resources are administered through a trust 
managed at the federal level by the National Commission for Social Protection of Health 
(NCSPH), the agency responsible for the implementation and operation of Seguro Popular. 
Interventions subject to coverage are drawn from a list of interventions previously 
identiﬁ ed by the General Health Council as those likely to be ﬁ nancially catastrophic for 
the individual patient. The National Comission reimburses providers using preset tariﬀ s 
for every intervention. Only interventions explicitly covered by the fund and delivered by 
certiﬁ ed providers are amenable to reimbursement.
The growing evolution and operational complexity of FPCHE is portrayed in the number of 
covered interventions and the caseload. The annual budgetary allocation to FPCHE has 
increased more than 12-fold between 2004 and 2011 as the number of enrollees grew. In 
2011, the resources allocated to this fund amounted to US$700 million and is increasing.42–44 
In 2004, only six interventions related to four diseases (HIV/AIDS, cervical cancer, acute 
lymphoblastic leukaemia in children and adolescents, and cataract surgery) were covered, 
and by the end of 2011 the ﬁ gure had reached 57 interventions with a further expansion 
planned in 2012. Interventions currently covered are associated with a growing set of 
diseases and health disorders including among others all childhood, breast, prostate, and 
testicular cancers, corneal transplantation, acute myocardial infarction in adults younger 
than 60 years, and congenital and acquired malformations amenable to surgery. The total 
number of reimbursed cases per year increased from 2661 in 2004 to 172 945 in 2011.42,44 In 
2011, the largest budget shares corresponded to HIV antiretrovirals (about 40%), breast 
cancer (close to 25%), and neonatal intensive care (about 15%).44
Health Policy
www.thelancet.com   Vol 380   October 6, 2012 1265
Law, the rhythm of enrolment gained momen tum.50 A 
special compensatory fund was established to allow for 
transition for states where the new reim bursement rules 
required large budgetary adjustments.
Yet, universal health coverage proved unattainable in 
2010. This was partly because of the economic crisis and 
the H1N1 epidemic, which redirected funds allocated for 
Seguro Popular expansion into purchase the ﬂ u vaccine 
and antiviral drugs, as well as to support other measures 
to deal with the epidemic.” Additional challenges 
included increasingly diﬃ  cult to enrol population groups 
(eg, high-income individuals), and poor supply capacity, 
especially in rural settings. As a result, the timeline and 
budget to achieve universal coverage was extended from 
December, 2010, to December, 2011.50
Another major adjustment was the implementation 
of expenditure controls for states. The 32 state 
governments are responsible for spending 89% of total 
resources of the Seguro Popular to ﬁ nance the delivery 
of the essential package of health interventions. 
Agreements signed between the federal government 
and every state set clear rules on the annual transfer 
and allocation of resources.
Because of the high degree of heterogeneity in the use 
of resources across states,51 since 2008, regulations for the 
use of federal resources and the annual service agreements 
limit expenditures by item. States can spend a maximum 
of 40% of total federal allocation on personnel, and 30% 
on medicines, materials, and other inputs.
It also proved necessary to regulate the purchase prices 
of medicines as there were large variations for both 
generics and patented drugs that could not be explained 
by local market conditions or volumes tendered.52 This 
prompted greater monitoring of purchasing, integration 
of information, and the design of better guidelines for 
the eﬃ  cient procurement of medicines by the states. 
Reference prices were established and states cannot 
purchase drugs with federal funds at prices more than 
20% above this level. For on-patent drugs, states can 
beneﬁ t from federally negotiated prices that aggregate 
the federal Ministry of Health, IMSS, and ISSSTE. 
However, some states still purchase at prices well above 
the reference suggesting the need for further 
improvement in drug purchasing mechanisms.53
Coresponsibility—exercising rights while complying 
with obligations—is a key element of the Mexican 
reform. In the initial design of the reform, the main 
instrument for coresponsibility was family coﬁ nancing. 
As enrolment progressed, it became evident that only a 
few enrollees—about 1% of families by the end of 
2011—were paying the family premium.44
A new modality of coresponsibility was introduced 
through health promotion and a strategy of wellness 
check-ups. Consulta Segura is an integral part of the 
Mexican government’s response to increase immun-
isation coverage and deal with major risk factors 
including unhealthy behaviour (tobacco and alcohol use), 
obesity, and high blood pressure, and thus, to prevent 
chronic and catastrophic illness.54
The check-up is compulsory for any person at the time 
of enrolment or re-enrolment and hence encourages 
beneﬁ ciaries to invest in their own health maintenance. 
It is designed to take 10 min and is integrated into the 
enrolment process, which typically takes place at a local 
hospital or clinics where modules have been set up.
The objective of this strategy is to build a risk proﬁ le of 
every beneﬁ ciary, promote a shift from curative to 
preventive care, and generate a registry and a system for 
early detection. The strategy has four components: a 
privacy-protected, ﬁ ngerprint registry of all beneﬁ ciaries 
aged 10 years and older; basic screening for health risks; 
targeted medical care in response to the results of the 
check-up; and an integrated health information system 
useful for the development of future electronic health 
records. Consulta Segura has expanded rapidly and since 
2010, more than 11 million individuals have been registered 
and almost 5 million screenings have been done.
Budgetary provisions for primary prevention have also 
been reinforced. As of 2008, annual budgets force the 
states to invest 20% of all Seguro Popular funds on 
prevention. This complements the federally-run com-
munity health fund.54
Eﬀ ects of the Mexican health reform
This section discusses the eﬀ ects of the reform on 
structural and process indicators including labour 
Figure 2: Evolution of vertical coverage: cumulative number of interventions covered by the Seguro Popular, 
the Fund for Protection against Catastrophic Health Expenditure, the Fund for Community Health Services, 
and the Medical Insurance for a New Generation, 2004–12
See appendix for a full list of data sources. MING=Medical Insurance for a New Generation (children born after 
Dec 1, 2006, and until they are 5 years old). FPCHE=Fund for Protection against Catastrophic Health 
Expenditures. EPHS=Essential Personal Health Services. EPI=Expanded Programme of Immunisations. 
CBP=Community-based package.
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markets, economic development, and ﬁ nance; followed 
by an examination of eﬀ ective coverage, health status, 
responsiveness, and ﬁ nancial protection.55 Evidence from 
published research and recently collected data by the 
Mexican Government are presented (panel 3).
Availability, distribution, and allocation of ﬁ nancial 
resources
National health accounts suggest improvement in 
ﬁ nancial imbalances (table 3). Total health expenditure 
grew from 4·4% of GDP in 1990 to 5·1% in 2000, and to 
6·3% in 2010.65 Total health expenditure per person 
increased from US$ purchasing power parity (US$ppp) 
508 in 2000 to US$ppp 959 in 2010, while government per 
capita health expenditure increased from US$ppp 237 in 
2000 to US$ppp 469.
Gaps between public and private expenditure are just 
beginning to close. Public spending as a percentage of 
total health expenditure increased from 46·6% in 2000 to 
48·9% in 2010.65
Additional public resources have been mainly 
allocated to institutions caring for the previously 
uninsured. Between 2000 and 2010, the Ministry of 
Health budget increased 142% in real terms whereas 
the budget of IMSS grew 42% and that of ISSSTE 103%. 
This narrowed gaps between Mexicans with access to 
social security and those without and the ratio of per 
capita public expend iture declined from 2·1 in 2000 to 
1·2 in 2010.66,67
The allocation of federal resources across states also 
improved. In 2000, the diﬀ erence between the state 
receiving the greatest allocation of federal resources per 
person and the state least favoured was 6·1 to 1. By 2010, 
this diﬀ erence was 3 to 1 (table 3). Variations in state 
contributions to ﬁ nancing declined somewhat, as shown 
by the small drop in the coeﬃ  cient of variation between 
2000 and 2010.68 Further, the share of total public 
expenditure ﬁ nanced by the states has been increasing 
slowly but consistently since the creation of Seguro 
Popular.69 Finally, resources devoted to investment 
increased in absolute terms. As a proportion of the 
Ministry of Health budget, investment grew from 3·3% 
in 2000 to 4·4% in 2010.70
Labour markets and economic development
One concern about Seguro Popular is stimulating parts 
of the labour force that evade taxation and social security 
contributions, and thus risking long run economic 
growth. Reviews of this issue suggest that the material-
ised risk is small and the concern misformulated.15 
Conceptually, non-salaried work has been erroneously 
considered equivalent to informality, which in turn has 
typically been synonymous with active evasion of the 
formal sector, salaried employment and taxation.71 
Seguro Popular targets all non-salaried workers who 
cannot access social security because they do not have 
an employer. This group is much larger and not 
coincident with informality. It includes independent 
workers, professionals and agricultural labourers, as 
well as those who do not participate in the labour force 
(ie, home makers and elderly people).15
Empirically, most papers show the eﬀ ect to date of 
Seguro Popular on salaried and formal employment is 
either nonexistent, small, or restricted to speciﬁ c 
population subgroups.72–78 Only two of the nine studies 
found a relatively small, negative eﬀ ect on enrolment in 
social security.79,80 Further, movement is not out of 
salaried employment but rather into non-salaried work.
Measuring the outcome of Seguro Popular requires a 
longer term, causal analysis. Seguro Popular was 
developed as a response to structural inequity and 
ineﬃ  ciencies that prevailed in the Mexican health system 
and were already aﬀ ecting labour markets. Indeed, an 
Panel 3: Bibliometric analysis and databases
To document the progress in the intrinsic and instrumental goals of the Seguro Popular, we 
searched Medline, PubMed, and Google Scholar with keywords “Seguro Popular”, “System 
for Social Protection of Health”, and “Seguro Popular and health”. This search uncovered 
533 documents. In a second ﬁ lter, we added “Mexico” and “eﬀ ects” and/or “impact”, 
reﬁ ning the list to 184 documents. Although some work remains unpublished, 83 articles 
are available in peer-reviewed journals, of which 27 are international and 56 Mexican.
We further classiﬁ ed the 58 documents that analysed the eﬀ ects or impact of the Seguro 
Popular using the WHO 2000 framework for health system performance.33 Seven studies 
were devoted to the impact on health conditions, four to responsiveness, and ten to 
ﬁ nancial protection. Further, three reviewed the eﬀ ects on stewardship, 11 on ﬁ nancing, 
three on resource generation, 14 on inputs and services, and another six on other sectors, 
speciﬁ cally the labour market.
Additionally, we accessed several databases either directly or through published 
information used in regular administrative evaluations published by the Ministry of 
Health. These databases include the National Household Income and Expenditure Surveys 
(Encuesta de Ingresos y Gastos de los Hogares),56 the National Survey of Demographic 
Dynamics (Encuesta Nacional de la Dinámica Demográﬁ ca; ENADID),57 and the National 
Survey of Health and Nutrition (Encuesta Nacional de Salud y Nutrition; ENSANut).58 For 
the National Survey of Health and Nutrition, we reviewed the 2000, 2006, and 
2012 surveys, although for the 2012 survey, only national-level estimates were available 
because the survey was recent.
We also analysed data from administrative reports and evaluations undertaken by the 
Ministry of Health. These data included a third round of evaluation of the Seguro Popular 
published only in Ministry of Health reports,59 that served as a partial (due to sample 
attrition issues) follow-up to the experimental evaluation undertaken in 2005–06.60
Most studies and data available provide descriptive results. Further, some of the data are 
only available at the national level and overall improvement cannot be exclusively 
assigned to Seguro Popular. Although not recent and spanning only 11 months of the 
coverage of the Seguro Popular, the 2005–06 experimental evaluation does allow for 
causal interpretation.60 Further, several studies have been produced that use econometric 
techniques to analyse outcomes and causality.61–64
The availability of data, and particularly the ENSANut 2012, should spawn a new cadre of 
studies. Further, a new round of the 2005–06 evaluation, combined with more detailed 
econometric analysis of the 2008 evaluation follow-up,59 could eﬀ ectively shed light on 
the progress of the Seguro Popular.
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objective of the 1997 reform of IMSS was reducing 
informality. Meta-analysis suggests that future research 
and policy questions, given the many positive eﬀ ects of 
Seguro Popular, should consider how to minimise labour 
market eﬀ ects. This includes focusing on improving the 
eﬀ ectiveness of IMSS.81
From an ethical perspective, to deny access to health 
care on the basis of type or absence of employment is 
indefensible. It is also unnecessary. Numerous policy 
instruments to stimulate salaried employment can be 
disassociated from health care. Indeed, labour market 
performance is largely deﬁ ned by policies outside of 
health, such as overregulation.82
A longer-term approach is required to conceptualise 
and eventually measure the full impact of Seguro Popular 
on labour markets and economic development. Invest-
ment in health can stimulate productivity and catalyse 
investments in education.83–86 Although it is too early to 
measure the full eﬀ ect of Seguro Popular on labour 
market productivity and economic growth through 
improved health, this eﬀ ect is likely to overwhelm small, 
short-run implications for informality.
Enrolment and covered services
Coverage of public health insurance improved substan-
tially between 2002 and 2011. Seguro Popular enrollees 
reached 52·6 million in April, 2012 (ﬁ gure 3). Most 
belong to the poorest four income deciles, 35% reside in 
rural communities (compared with 22% nationally), and 
close to 9% belong to indigenous communities (com-
pared with 6% nationally).44,87
In 2002, over 60 million Mexicans did not have any 
institutional form of ﬁ nancial protection in health. 
Although substantial debate concerning total coverage 
numbers exists, particularly for IMSS, a conservative 
estimate of the total number of Mexicans who had 
health insurance in 2002 is 41·5 million (38·7 million 
through social security and 1·8 million exclusively by 
private insurance).88,89 By 2010, social security had 
increased to 59·2 million, and Seguro Popular enrolment 
reached 43·5 million.44,90 An additional 8·3 million 
people enrolled in Seguro Popular in 2011. Thus, 
accounting for duplicate coverage between insurance 
schemes, about 110 million—almost 98% of Mexican 
residents—were registered with a health insurance 
entity by the end of 2011.87 Further, the Ministry of 
Health 2012 budget is suﬃ  cient to ensure that all who 
do not have access to social security, taking into account 
population growth, can be aﬃ  liated voluntarily to Seguro 
Popular. Thus, as of 2012, Mexico is on track with 
universal coverage.
Both enrolment and the number of covered inter-
ventions in each package have expanded continuously 
(ﬁ gure 2 and panel 2). The package of essential services, 
for example, grew from 91 interventions in 2004, to 
284 in 2012, covering treatment for more than 95% of 
causes in ambulatory units and general hospitals.
Health infrastructure, human resources, and availability 
of drugs
Health infrastructure—both of Ministry of Health and 
social security—grew over the decade. Between 2001 and 
2011, 15 high-specialty centres were built as were more 
than 200 hospitals and almost 2000 ambulatory clinics.91,92 
Additionally, more than 4000 facilities were renovated or 
equipped.
Additional personnel were hired with Seguro Popular 
resources.93 The physician (general and specialist) to 
population ratio increased by 54% between 2004 and 
2010, compared with 7% between 2000 and 2004. Further, 
the availability of nurses increased by 29% between 
2004 and 2009, compared with a 1% decrease between 
2000 and 2004.52,94,95
Still, the expansion of the human resource base 
remains a challenge, especially in a decentralised health 
system. Most new personnel were initially hired by 
states with variable, short-term contracts. The situation 
improved as contract terms lengthened, legally-mandated 
Indicator 2000 2004 2010
Level Health expenditure as percentage of GDP 5·1% 6·0% 6·3%
Source Out-of-pocket health expenditure as percentage of 
total health expenditure
50·9% 51·7% 47·1%
Distribution Ratio of per-person public expenditure between 
those covered by social security agencies and those 
without social security
2·1 to 1·0 2·1 to 1·0 1·2 to 1·0
Distribution Ratio of federal per-head expenditure on health in 
the state with the highest ﬁ gure to that in the lowest
6·1 to 1·0 4·3 to 1·0 3·0 to 1·0
State 
contribution
Variability in state contribution to health-care 
ﬁ nancing (coeﬃ  cient of variation)
1·0 0·8 0·7
Allocation of 
funds
Percentage of MoH budget devoted to investment 3·3% 3·1% 4·4%
See appendix for data sources. GDP=gross domestic product. MoH=Ministry of Health. 
Table 3: Evolution of ﬁ nancial imbalances in the health sector, Mexico 2000–10
Figure 3: Evolution of enrolment to Seguro Popular, Mexico 2004–12
See appendix for a full list of data sources.
2004 2005 2006 2007 2008
Time (year)
2009 2010 2011 April
2012
Ac
cu
m
ul
at
ed
 a
ﬃ
lia
tio
n 
(p
op
ul
at
io
n 
in
 m
ill
io
ns
) Public health expenditure per head of population 
w
ithout social security (US$ 2010)
0
10
20
30
40
50
60
0
50
100
150
200
250
300
Health Policy
1268 www.thelancet.com   Vol 380   October 6, 2012
beneﬁ ts were introduced, and salaries were standard-
ised.52 Initial imbalances created by over-hiring admin-
istrative staﬀ  have been largely corrected.
Seguro Popular ﬁ nancing has also been channelled 
into access to essential drugs. In 2002, 55% of patients 
reported prescriptions in ambulatory clinics of the 
Ministry of Health as fully ﬁ lled.96 In 2011, this number 
reached 62%.97 For social security institutions, the 
proportion of prescriptions correctly and completed ﬁ lled 
also increased over the same period (from 70% to 87%).98
Use of health services
Based on the 2006 ENSANut, Seguro Popular enrollees had 
a higher probability of service use, conditional on perceived 
need, than did uninsured individuals.13,99 The 2006 National 
Satisfaction and Responsiveness Survey done in 
74 hospitals nationwide showed that Seguro Popular 
enrollees had a higher probability of using hospital services 
for elective surgeries, diabetes, and hypertension than did 
the uninsured.100 Another study showed an increase in the 
probability of visiting a health unit.61
Use of health services for childbirth between 2000 and 
2012 provides additional support. The proportion of 
births in private entities declined from 25% to 19%, and 
in social security facilities from 35% to 26%. By contrast, 
use of public, Ministry of Health facilities increased from 
32% to 48% (ﬁ gure 4).
By contrast, the short-term, 2005–06 assessment60 
showed no measurable eﬀ ect on service use. Still, in 
the follow-up assessment for 2008, Seguro Popular 
house holds registered 3·3 health visits per year, which 
was signiﬁ cantly higher than the visits registered by 
non-Seguro Popular households and similar to social 
security.59,101
Impact on eﬀ ective coverage and health conditions
Both maternal and child mortality continue to decline. 
From 1990, the baseline year for the Millennium 
Development Goals (MDGs), mortality in children 
younger than 5 years fell from 47·1 per 1000 livebirths to 
16·7 in 2010.69 Projections indicate that Mexico will meet 
the MDG 4 target before 2015.102,103
Interventions to reduce maternal mortality are targeted 
to MDGs 4 and 5. Fair Start in Life, a national pro gramme 
launched in 2001, includes a safe motherhood component 
that strengthens care networks and inputs, most notably, 
a safe supply of blood. Special measures were 
implemented to expand coverage of antenatal care and 
access to institutional deliveries, with emphasis on 
timely diagnosis, high-risk pregnancies, and emergency 
responses. Closer monitoring and detailed review of 
maternal deaths through verbal autopsies were imple-
mented. Maternal mortality numbers declined substan-
tially from 90·4 per 100 000 livebirths in 1990 to 51·5 in 
2010, yet meeting MDG 5 will require further reductions 
that are especially challenging to achieve.
Improvements in maternal mortality and in mortality 
in children younger than 5 years have been larger for 
the previously uninsured than for social security 
beneﬁ ciaries. Mortality in children younger than 5 years 
fell by 11% for the population without social security 
compared with 5% for those with access. Maternal 
mortality fell by 32% for those without social security 
compared with 3% for those with access (table 4).
Coverage and eﬀ ective coverage (when measurable)3 
have increased. Between 2000 and 2006 coverage for 
prenatal care and childbirth, immunisation (BCG 
[Bacillus Calmette–Guérin], DPT [diphtheria, pertussis, 
and tetanus], and measles vaccines), care of premature 
newborn babies, treatment of diarrhoea and acute 
respira tory infections in children, mammography, 
cervical cancer screening, and treatment of hypertension 
improved, concentrated in the poorest states and income 
deciles.11,104
With a composite indicator of interventions, in 
2006 Seguro Popular enrollees had signiﬁ cantly higher 
levels of coverage than did the uninsured.13 Further, 
individuals with social security had signiﬁ cantly higher 
composite coverage than the uninsured in 2000, but by 
2006, the diﬀ erences with Seguro Popular enrollees were 
insigniﬁ cant. Controlling for observable diﬀ erences, 
Seguro Popular enrollees had signiﬁ cantly more coverage 
than the uninsured for hypertension treatment, 
mammography, cervical cancer screening and acute 
respiratory infections in children. For interventions 
covered in long-standing national programmes (ie, 
childhood immunisations) the diﬀ erences were, as 
expected, insigniﬁ cant.
ENSANut data from 2006 and 2012 show further 
improvement (table 5). Coverage for measles and BCG 
has remained high and close to the same level (90·1% for 
measles and 97·1% for BCG), and has increased a few 
points for DTP3 (88%). Diarrhoea treatment has 
increased slightly and encouraging and signiﬁ cant 
improvements exist in coverage of acute respiratory 
infections in children younger than 5 years.
Figure 4: Childbirth by type of care facility, Mexico 2000–12
Estimated by the authors on the basis of original data sources cited in the appendix.
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Skilled birth attendance reached 94·9% in 2006, and 
94·4% in 2009, according to the national demographic 
survey of 2009 (Encuesta Nacional de la Dinámica 
Demográﬁ ca; ENADID).11,105 The ENSANut shows that 
rates continue to be close to 92%, and suggests a major 
improvement in coverage of prenatal care from 67·3% in 
2006 to 81·3% in 2012 (table 5; panel 4).
Progress has been made in prevention, early detection, 
and treatment of cervical cancer, although the poorer, 
southern states continue to have higher incidence and 
death rates than the richer.109–111 Screening coverage 
increased from 30% in 2000 to 43·8% in 2006, and 48·5% 
in 2012 (table 5).13 Additional to traditional cytological 
examinations, in 2008, the Ministry of Health introduced 
tests to identify human papillomavirus DNA sequences.69 
Further, between 2008 and 2010, the human papil-
lomavirus vaccine was applied for the ﬁ rst time to teenage 
girls in the 125 poorest municipalities. As of 2012, the 
vaccine is being applied to all 9-year-old Mexican girls.
Access to breast cancer treatment shows promising 
signs of improvement. By 2010, FPCHE was ﬁ nancing 
treatment for more than 17 000 women.112 National data 
are unavailable, but the numbers from the largest, public 
specialty cancer centre, the National Institute of Cancer 
of Mexico, indicate that adherence increased.110 In 2005, 
about 30% of the 600 women diag nosed with breast 
cancer abandoned treatment within a year. In 2010, less 
than 1% of 900 women abandoned treatment.113 The 
package of covered services is broad—trastuzumab for 
example, was included in 2008.114 Still, most patients with 
breast cancer begin treatment at advanced stages. 
ENSANut data show that screening rates have remained 
constant at about 20%.
Seguro Popular funding for childhood cancer is 
channelled to drug access, regional centres of excellence, 
and paediatric oncology training. Abandonment of treat-
ment has declined to 5% (from about a third between 
2000 and 2005), and 30-month survival rates for acute 
lymphoblastic leukaemia—covered since 2005—have 
increased to over 60% in several of the accredited hospitals. 
Still, the variance in outcomes across hospitals indicates 
opportunities for improvement as capacity is built.115,116
Between 2000 and 2006, hypertensive and diabetic adults 
with Seguro Popular had a signiﬁ cantly higher probability 
of receiving treatment than did the uninsured.62,63 
Furthermore, Seguro Popular beneﬁ ciaries with diabetes 
showed better blood glucose levels.63 These data show 
important improvement over the period of the reform. 
Although causality cannot be inferred from the available 
data on mortality and coverage, a likely association with 
the expansion of Seguro Popular merits further research.
Responsiveness
In the 2005–06 Seguro Popular assessment,60 69·8%  of 
Seguro Popular enrollees rated health services received as 
2004 2010 Percentage of change
Social 
security* (a)
Non-social 
security* (b)
Gap† 
(c=a/b)
Social 
security* (d)
Non-social 
security* (e)
Gap† 
(f=d/e)
Social security* 
(g=([d/a]–1)×100)
Non-social security* 
(h=([e/b]–1)×100)
Health conditions: mortality
Deaths in children younger than 5 years (per 1000 livebirths) 12·8 25·0 0·5 12·1 22·3 0·5 –5·2 –11·0
Maternal deaths (per 100 000 livebirths) 28·7 72·2 0·4 27·9 48·9 0·6 –2·9 –32·3
Financial protection
Out-of pocket health expenditure by households as a proportion of 
total income (%) 
3·0% 4·4% 0·7 2·6% 3·2% 0·8 –14·2% –27·6%
Out-of pocket health expenditure by households as a proportion of 
disposable income (%)
3·7% 5·9% 0·6 3·3% 4·6% 0·7 –10·8% –21·9%
Percentage of households with catastrophic health expenditures 1·5% 3·6% 0·4 1·4% 2·8% 0·5 –10·0% –20·6%
Percentage of households with impoverishing health expenditures 0·2% 2·1% 0·1 0·1% 1·6% 0·1 –51·9% –25·0%
Estimated by the authors on the basis of original data sources cited in the appendix.*Social security refers to the population covered by social security institutions, while non-social security refers to the 
population without access to health care through social security institutions, that is the previously uninsured population targeted by the Seguro Popular. †Gaps shown correspond to the ratio of the value 
observed for the insured by social security divided by the corresponding value for the previously uninsured; they are read as the number of times the value for those insured by social security exceeds the value for 
the previously unsinsured. The closer to one, the greater equality between population groups.
Table 4: Progress in closing the gaps between population groups, health conditions, and ﬁ nancial protection
2006 2012 Diﬀ erence
Measles immunisation in children (18 months and 59 months) 92·0 90·1 –1·9*
DTP3 immunisation in children between (18 months and 59 months) 85·6 88·0 2·4*
Bacillus Calmette–Guérin (BCG) immunisation in children younger 
than 5 years
97·8 97·1 –0·6
Antenatal care 69·1 81·3 14·0*
Skilled birth attendance 94·9 91·8 –1·5
Treatment of acute respiratory infections in children younger than 
5 years
58·1 63·8 5·7*
Treatment of diarrhoea in children younger than 5 years† 59·2 61·3 2·1*
Breast cancer screening in women aged 40–69 years (mammography) 21·6 20·1 –1·5
Cervical cancer screening in women aged 25–64 years 43·8 48·5 7·3*
Estimated by the authors on the basis of original data sources cited in the appendix. *Signiﬁ cant diﬀ erences. †The 
indicator diﬀ ers from Lozano and colleagues11 since it is restricted to include packaged oral rehydration therapies only. 
Table 5: Coverage of speciﬁ c health-care interventions, Mexico, National Surveys of Health and Nutrition 
(ENSANut) 2006 and 2012
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very good or good, 85% reported that beneﬁ ts were well 
communicated, 94% that they were well treated, and 97% 
planned to re-enrol.60
The Ministry of Health is legally obligated to undertake 
nationally representative surveys of users of Seguro 
Popular. In 2011, 97% of the roughly 22 000 people 
interviewed with health facility exit poll surveys reported 
satisfaction with services received and more than 95% 
praised the interpersonal quality and ease of making 
appointments. Almost all (99%) reported that they would 
re-enrol, 30% because they did not have to pay fees at 
time of service, and 24% because of quality of care.117 
Comparing 2004 and 2011, perception of primary care 
treatment improved slightly as did the access to 
information from the primary care physician.117 Waiting 
times in outpatient services decreased, but increased in 
emergency wards.118
Similarly, ENSANut show improvements between 
2006 and 2012 in perception of care as good or very good. 
The number increased from 79·1% to 84·6%.
Certiﬁ cation and accreditation have expanded and 
9592 of 12 743 units became accredited between 2004 and 
2010. This helps patients to identify high-quality services.119
Independent regional initiatives have also been col-
lecting information. Latinobarómetro considered Seguro 
Popular the most beneﬁ cial public policy implemented in 
Mexico in that period.120
Financial protection
Evidence shows signiﬁ cant progress in reduction of 
catastrophic health expenditure (CHE, 30% of capacity to 
pay) and impoverishing health expenditure (IHE, house-
holds forced below or further below a poverty line). 
Catastrophic and impoverishing health-care payments 
from 1992 to 2010 show a long-run downward trend 
(ﬁ gure 5).12,121 In 2000, 3·1% of households had CHE and 
3·3% had IHE. By 2010, the values had dropped to 2% 
for CHE and 0·8% for IHE.
Furthermore, the diﬀ erences between households 
with and without social security are decreasing (table 4). 
The diﬀ erential share of out-of-pocket spending in 
household income and CHE fell for all groups between 
2004 and 2010, especially for families without social 
security. IHE fell from 0·2% to 0·1% for households 
with social security, and from 2·1% to 1·6% for the rest 
of the population.
Notably, the drop in CHE is evident despite the small 
reduction in levels of out-of-pocket spending as a 
proportion of spending on health. This suggests that 
households are spending out of pocket, but not in ways 
that threaten their economic wellbeing or ability to cover 
basic needs.
Based on analyses of the ENIGH, the proportion of out-
of-pocket spending ﬁ nanced by the poor and those with 
Seguro Popular has fallen. 13·7% of total out-of-pocket 
spending in 2002, and 12·8% in 2004 came from the 40% 
poorest households. By 2010, the value had dropped to 
Figure 5: Trends of catastrophic and impoverishing health expenditure in Mexico, 1992–2010*
Estimated by the authors on the basis of original data sources cited in the appendix. *Catastrophic expenditure is 
measured as 30% or more of capacity to pay in turn proxied by total household expenditure less spending on food. 
Impoverishment is measured as households falling below the poverty line equivalent to $1 purchasing power 
parity, or deepening impoverishment if below the poverty line.
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Panel 4: Dynamic, eﬀ ective universal health coverage: expanded immunisation and 
investment in child health
In 1989, a measles epidemic started in Canada, and eventually reached Mexico. 
Consequences were fatal in malnourished Mexican populations. In the USA, 120 of 
55 000 reported cases died. In Mexico, more than 6000 children younger than 5 years 
died, concentrated in the poorest, southern states.14
The prevailing wisdom suggested that one dose of measles vaccine was enough for 
lifelong protection and that 80% vaccination coverage in the child population would 
prevent outbreaks. Further, administrative records in Mexico were overestimating 
eﬀ ective coverage and providing a false sense of security.
This epidemic spurred the coinage of the term “immunological equity”, which was to be 
achieved through a universal vaccination programme whose audacious goal was “all the 
children; all the vaccines” by October, 1992.
Polio and measles were eliminated. Major public health interventions available at that 
time—vaccines, vitamin A, albendazole, oral rehydration therapy—have been delivered 
since then three times a year to all children and communities. 
This public health policy has been expanded by successive administrations, leading to 
measurable improvements in the health and nutrition of Mexican children.14 Further, an 
integrated set of platforms now exist with a prochild focus that include nationwide, 
conditional cash transfer programmes such as Oportunidades, which has had measurable 
eﬀ ects on child development.106,107
Since the 2003 reform, the immunisation package has been expanded and now contains 
12 vaccines, including those for rotavirus, pneumococcus, and human papillomavirus. As 
of 2011, two doses of human papillomavirus vaccine were included in the Seguro Popular 
for girls.
The implementation of the Seguro Popular has resulted in a comprehensive investment by 
Mexico in child health, which since December of 2006, includes a broad range of 
treatments and services. All newborns are covered by the programme through Medical 
Insurance for a New Generation. Indeed, spending through Seguro Popular on children 
below the age of 16 increased from $US12 million in 2007 to $102·6 million in 2011, and 
the number of covered children from about 800 000 to 5·8 million.108
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11·4% of total out-of-pocket spending. The percentages 
are 58·2% in 2002, 52·8% in 2004, and 35·7% in 2010 for 
the uninsured and Seguro Popular enrollees.
The 2005–06 assessment results show that Seguro 
Popular is reducing out-of-pocket spending and pro-
viding ﬁ nancial protection, especially for the poorest 
households, with a 23% reduction from baseline in 
CHE.60,122 The ﬁ ndings were conﬁ rmed in the follow-up 
in 2008.59,101 Seguro Popular enrolled households were 
signiﬁ cantly less likely than either households with 
social security or without any ﬁ nancial protection, to 
spend out of pocket on drugs or outpatient services. 
Seguro Popular households also had a signiﬁ cantly lower 
rate of CHE than did households eligible for Seguro 
Popular and not yet enrolled, and lower, although not 
signiﬁ cantly diﬀ erent, to households with access to 
social security.
Recent studies conﬁ rm this protective eﬀ ect of Seguro 
Popular, especially among urban households and for 
prescription drugs and in rural areas with access to 
health facilities.64 Still, the studies highlight the persistent 
challenge of protecting households in remote rural areas 
with very limited access.
Ongoing challenges to the SSPH
Seguro Popular is successfully closing the gaps in health 
ﬁ nancing across population groups. The gap in the per 
capita allocation of public resources fell more than 70% 
between 2004 and 2010 (table 6).
Yet, mobilising additional funds to extend health 
insurance coverage is a necessary but not suﬃ  cient 
condition to expand access to comprehensive health 
care and decrease reliance on out-of-pocket spending. 
Translation of additional ﬁ nancial resources into 
regular access to comprehensive, eﬀ ective health 
services—the ultimate goals of eﬀ ective universal 
coverage—is a formidable task. Until universal access 
includes a guaranteed, acceptable level of quality, the 
egalitarian exercise of the right to protection of health 
will remain an elusive goal and ineﬃ  cient out-of-pocket 
spending will grow. Further, without eﬃ  cient use of 
current resources, generating the additional ﬁ scal space 
required to face the burden of chronic diseases is 
politically unfeasible.
Gaps and inequities in public funding across 
institutions and hence populations have been reduced. 
Yet the reliance on ineﬃ  cient out-of-pocket spending 
as a source of health ﬁ nancing has not declined 
substantially. Out-of-pocket spending persists (alongside 
reductions in the prevalence of catastrophic spending) 
because families face issues with access and quality. 
Finally, gaps in access persist because of continuous 
limitations in crucial health-care inputs, especially 
human and organisational resources.
2004 2009–10* Percentage of change
Social 
security† 
(a)
Non-
social 
security 
(b)
Gap‡ 
(c=a/b)
Social 
security† 
(d)
Non-
social 
security 
(e)
Gap‡ 
(f=d/e)
Social security† 
(g=([d/a]–1)×100)
Non-social security 
(h=([e/b]–1)×100)
Progress 
in gap 
reduction 
(%)§
Financing
Public resources per capita (US$ PPP) 209 102 2·1 237 205 1·2 13·1 102·2 74·2%
Service provision: activity levels (rate per 1000)
Outpatient consultations: general 1865 1626 1·3 2110 1834 1·4 13·1 12·8 –2·0%
Outpatient consultations: specialty 1137 438 3·0 1226 573 2·6 7·9 30·9 13·3%
Hospital discharges 55 39 1·7 54 49 1·3 –2·3 25·8 69·7%
Service provision: productivity
Consultations per general physician 16·8 12·3 1·4 17·8 11·1 1·6 5·9 –9·9 –41·1%
Consultations per specialist physician 2·9 1·6 1·8 2·3 1·6 1·4 –20·5 2·4 35·7%
Hospital bed occupancy rates (%) 76·0 68·7 1·1 81·8 70·7 1·2 7·6 2·9 –41·2%
Resource generation (rate per 100 000)
General doctors 41 32 1·3 50 50 1·0 21·7 57·9 100·0%
Specialist doctors 78 40 2·0 90 60 1·5 15·7 51·6 32·2%
Nurses 232 155 1·5 250 200 1·3 7·9 29·2 39·8%
Hospital beds 88 62 1·4 80 70 1·1 –9·3 13·3 58·3%
PPP=purchasing power parity. *All data except for the indicator on ﬁ nancing (2010) correspond to 2009. †Social security refers to the population covered by social security 
institutions, while non-social security refers to the population without access to health care through social security institutions, that is the previously uninsured population 
targeted by the Seguro Popular. ‡Gaps shown correspond to the ratio of the value observed for the insured by social security divided by the corresponding value for the 
previously uninsured; they are read as the number of times the value for those insured by social security exceeds the value for the previously uninsured. The closer to one, the 
greater equality between population groups. Although the rates shown do not fully control for diﬀ erences in age, sex, or epidemiological proﬁ le, gaps in activity levels have 
been adjusted by the diﬀ erence in mortality rates between both population groups. §Progress in gap reduction is measured as the percentage change in the relative gap 
ratios between the 2 years analysed with the following formula (1 – [(e – d) / d] / [(b – a) / a]) × 100.
Table 6: Progress in closing the gaps between population groups by health system function
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A benchmark of reform was to close gaps in public 
ﬁ nancing between the previously uninsured and those 
with access to social security, and this goal has been 
largely achieved. Between 2000 and 2010, average out-of-
pocket spending as a proportion of income and 
disposable income fell. Most of the decline occurred 
in the previously uninsured population (later Seguro 
Popular enrollees) from 6·3% in 2000, to 5·9% in 2004, 
and 4·6% in 2010. By contrast, for households with social 
security, out-of-pocket spending as a proportion of 
income remained quite constant.
Yet the reduction in out-of-pocket spending has been 
less than proportional to the increase in ﬁ nancial 
resources (tables 4 and 6). Private spending still 
accounts for 51% of total health expenditure (out of 
pocket is 47·1%; table 3). Thus families continue to rely 
on out-of-pocket spending—although at levels that 
generate less CHE.
Gaps in access to health care between those with social 
security and the previously uninsured who currently have 
Seguro Popular have also narrowed. Increased access is 
associated with higher utilisation of health services. 
Although the use of outpatient consultations and hospital 
services have improved over time for the previously 
uninsured, rates of utilisation are still higher in social 
security beneﬁ ciaries, as are diﬀ erences in specialty 
consultations. The gap in the number of consultations per 
specialty physician is narrowing, yet diﬀ erentials in 
general consultations and bed occupancy rates have 
increased (table 6). Thus, deﬁ ciencies persist, especially 
for some segments of the population and in speciﬁ c states.
The Seguro Popular design includes supply-strength-
ening components to enhance provider responsiveness to 
patients’ needs and expectations. Increased ﬁ nancing has 
generated improved supply of pharmaceuticals, expan-
sion of facilities, and hiring of personnel. Despite this, 
some critical inputs still lag. For example, although the 
gap in availability of general physicians was essentially 
closed between 2004 and 2009, diﬀ erences persist for 
specialists and nurses (table 6). Another problem is 
resource mobilisation and allocation. This includes slow 
ﬂ ow of resources from federal to state and in turn to local 
levels, as well as under-spending, poor transparency and 
accountability, and poor managerial performance in the 
transfer and use of resources among states. In its initial 
phases, Seguro Popular focused 45% of transfers to the 
states on supporting the purchase of medicines and basic 
medical supplies.123 By 2009, this share fell to 20% as the 
demand to cover salaries increased.123
Next steps of implementation require that the current 
bottlenecks, especially in some specialties, be solved. 
Yet this cannot be immediately remedied as it takes 
time to train specialists. For example, to meet the 
demand for breast cancer treatment in Seguro Popular, 
between 200 and 350 radiation oncologists are needed; 
yet only about 25% of this ﬁ gure were available when 
the disease was included in the catastrophic fund.124 
Indeed, there is evidence of increasing underuse of 
high-specialty facilities because of scarcity of personnel. 
Average occupancy rates in the new high-specialty 
hospitals are 70%—a number that will improve as more 
specialists are deployed.125
Finally, improving access in remote rural areas is a 
challenge.126 Although rural areas include only a minority 
of the population (1% live in localities that do not have 
access to public transportation and have fewer than 
2500 inhabitants, and 5·4% live in localities with less 
than 5000 inhabitants), they are a vulnerable, dispersed, 
and hard-to-reach group.126 In remote com munities, 
health centres continue to operate with poor basic 
services, poor telecommunications infrastructure, and 
are often staﬀ ed by medical students.127 Still by 
2009, about 50% of these centres were formally 
accredited, a required condition in order to provide 
services to Seguro Popular beneﬁ ciaries.127
Future planning must account for population ageing 
and the growing burden of chronic illness. Although the 
number of diseases and interventions covered by the 
FPCHE has grown, there are still a host of common, 
costly, treatable chronic diseases that are not covered, 
including several cancers. This issue is a challenge for 
ﬁ nancing and for equity; patients with these diseases 
suﬀ er severe economic hardship or go without treatment. 
The prevailing models of ambulatory care were 
designed to treat acute disorders. Special eﬀ ort will be 
needed to increase the capacity of primary health centres 
to deal with chronic disorders. This implies training in 
pre vention, early detection, and treatment of chronic 
illness, and strengthening telemedicine. Similarly, 
capacity is sorely missing for long-term and palliative 
care. Further, prevention and appropriate management 
of chronic illness—through initiatives such as the 
Consulta Segura—are essential to the long-term ﬁ nancial 
sustainability of the health sector. The FPCHE should 
not be overused as a source of ﬁ nancing for treatment 
because of deﬁ ciencies in control of risk factors, 
prevention, and early detection (panel 5).
Despite substantial improvement on many fronts, 
the persistent gaps and imbalances portray structural 
limitations in absorptive capacity for the substantial 
expansion in resources brought about by the reform. The 
competencies and structural changes needed to 
eﬃ  ciently manage expansion take time to mature. This 
point is especially relevant in the decentralised Mexican 
health system where states have diﬀ erent degrees of 
managerial capacity. Increased ﬁ nancial resources 
combined with weak management can lead to 
ineﬃ  ciency, and solid guidelines combined with careful 
monitoring are needed to avoid corruption.
A major challenge is to complete the reorganisation of 
the health system by functions. As mentioned above, 
consolidation of stewardship at the federal level was 
largely achieved and the ﬁ nancial architecture of the 
entire system was aligned. The next stage of reforms will 
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need a fully integrated ﬁ nancing scheme with ﬂ exibility 
and portability of beneﬁ ts to support delivery by a 
plurality of providers, both public and private.131
Another pending challenge is to implement the 
purchaser–provider split within states.131 The initial 
reform design envisioned a more eﬃ  cient arrangement 
for health-care delivery whereby states would develop the 
purchasing function of basic hospital and primary care. 
The state Seguro Popular fund holder would allocate 
monies through specialised service contracts to a network 
of public and private providers (including the states’ own 
hospitals and clinics) on the basis of popu lation needs, 
rewarding both eﬃ  cient and responsive care. Local 
provision of public goods and provider regulation would 
remain part of the stewardship function of state 
ministries, working with the federal Ministry of Health. 
Yet progress has been slow and uneven as lack of local 
capacity compounds with the pressing need to expedite 
the supply of basic interventions. 
Given successes in ensuring more money for health 
and ﬁ nancial protection, the emerging challenge for 
Seguro Popular is to achieve more health for money. The 
Mexican health system is ready for more reform to 
address prevailing ineﬃ  ciencies and inequities.
The future of the Mexican health system: a new 
generation of reforms
The ultimate objective of the 2003 Mexican health reform 
is the egalitarian realisation of the right to social 
protection of health, which entails generally applicable 
rules of access to a compre hensive package of services 
provided with similar quality and ﬁ nancial protection to 
all. To achieve this objective, the next stage of reform 
must encompass ﬁ nancial arrangements, managerial 
capacities, and operation of the health-care model.
Financial reform should be geared to improved 
resource mobilisation. This goal can be accomplished 
through an earmarked, social contribution for health 
with a combination of progressive, eﬃ  cient taxes.15,132 
This contribution would replace the payroll tax currently 
used to ﬁ nance much of health care for social security 
beneﬁ ciaries and would further expand general taxation 
allocated to health. It should be designed as a single 
insurance fund to ﬁ nance a common package of 
entitlements, including essential and high-specialty 
interventions, to which all Mexicans will have access 
regardless of the health-service provider.
The full ﬁ scal beneﬁ ts of replacing payroll con-
tributions should also include additional revenues from 
eliminating the basis on which ﬁ rms can deduct taxes 
and disincentivising informality. Pooling resources 
across the population would allow more eﬃ  cient risk 
aggregation, especially for high-cost conditions. This 
could help with expanded ﬁ nancial coverage of cata-
strophic interventions and help avoid adverse selection.
The purpose of the managerial reform is two-fold: to 
consolidate the separation of the ﬁ nancing and delivery 
functions in all public institutions, and to strengthen 
managerial capacity at all levels. The separation of 
functions guarantees provision by a plurality of providers, 
both public and private, favouring good performance and 
quality of care. Ensuring an eﬃ  cient articulation between 
payers and providers is essential to this process.131 
Strengthening managerial capacity requires a universal 
health identiﬁ cation number and card that would 
guarantee the portability of beneﬁ ts, as well as common 
capitation and reimbursement rates to help with mobility 
of users across providers and to enhance responsiveness.
The reform of the health-care model will adapt service 
delivery to meet the challenge of chronic disorders and 
injuries, by creating healthy environments and extension 
of health care beyond medical facilities. The new model 
should prompt the construction of com munity spaces for 
health promotion and emphasise prevention; create 
networks of services to assure the continuity of care, and 
integrate formal and informal spaces through the 
extension of the supply of health-care services to the 
home, schools, workplaces, and public areas. This model 
should harness telemedicine to reach remote areas, and 
regionalise the provision of high-specialty services.
In this process of consolidation, it will be important to 
protect the investment in non-personal, community 
health services. Reforms in other countries have suﬀ ered 
from not paying enough attention to public health.41 In 
Mexico, the next step is to adjust the law to assign a ﬁ xed 
Panel 5: Optimisation of the FPCHE through investment in health promotion
The Fund for Protection against Catastrophic Health Expenditures (FPCHE) covers a 
relatively small number of diseases and interventions for which costs of treatment are 
high. Without appropriate prevention or control of these diseases, the associated costs 
could quickly push the fund into deﬁ cit. An example is costly endstage renal disease, 
associated with diabetes, which is in turn closely related to the epidemic of overweight 
and obesity that must be controlled through health promotion.
In the case of breast cancer, access and adherence to treatment have improved 
substantially. The challenge, however, continues to be late detection, which implies 
dramatically reduced survival and higher costs per year of life saved.124,128 Investment 
expansion is required in the capacity to detect the disease in early stages. As a ﬁ rst step, 
a specialised training programme was developed for community health workers and 
primary-care physicians and nurses, and patient awareness and education were 
introduced into Oportunidades.129,130 Still, and despite important investments in the 
purchase of mammography units, the lack of specialised breast radiologists is a major 
obstacle, especially in certain states.69,124
An integrated approach is needed to meet the challenge of chronic illness and 
catastrophic interventions in Mexico. First, education and economic incentives are 
needed to manage risk factors and promote prevention. Second, health ﬁ nancing and 
delivery must be aligned to guarantee investment in all stages of chronic disease.129 In the 
case of the System of Social Protection in Health, this involves the three major funds—
community health, Seguro Popular funding for essential interventions, and the FPCHE—
since the management of some diseases requires a combination of public goods, essential 
personal health services, and highly specialised interventions. If investment is guaranteed 
only for treatment, results will be suboptimum both in terms of costs and lives saved.
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percentage of the health budget to the Fund for 
Community Health Services. To date, this Fund is 
ﬁ nanced through an annual allocation that is exposed to 
the ebbs and ﬂ ows of budgets, although the package of 
services is explicit and complementary funding has been 
identiﬁ ed through the provision for primary prevention 
in the Seguro Popular. Yet the potential economies of 
aggre gating and integrating interventions suggest that 
investing in upstream, preventive and early detection 
services—that tend to not have enough spontaneous 
demand—will reduce downstream costs and suﬀ ering, 
especially for chronic illness. This is the rationale for 
ﬁ xing a percentage for this fund.
Sound evidence must continue to guide the evolution 
of the entire health system. Thus, the new reforms must 
be accompanied by additional investments in health 
systems research, fuelled by a vigorous and rigorous 
programme of evidence generation, monitoring and 
assessment.
Global implications of the Mexican health 
reform
The Mexican health reform contributes knowledge to the 
global movement for universal health coverage. The 
experience is an example of successfully guaranteeing 
social protection of health to the non-salaried population 
through legislated access to a comprehensive package of 
services. Social protection in health is not limited to 
those with salaried employment; rather it is a universal 
right for all citizens, independent of their employment 
status. The experience of applying evidence to design 
policy and measure progress also provides models for 
strengthening stewardship.133
Indeed, the Mexican experience is being used as a 
reference in international work on quality134,135 and in 
designing strategies of universal coverage for countries at 
all levels of income. In April 2012, this interest resulted in 
a Mexico Declaration on universal coverage in an 
international forum jointly undertaken by the Mexican 
Ministry of Health and WHO that convened 21 countries.136
Various countries have or are undertaking health 
ﬁ nancing innovation with similarities to Mexico. The 
creation of an explicit package of services through the 
Regime of Explicit Health Guarantees (AUGE Plan) in 
Chile presents parallels with the Mexican FPCHE.137 
Another example is the South African systemic ﬁ nancial 
reform designed to equalise the entitlements of citizens 
with access to private insurance and those without.138,139 
India has produced an in-depth review of its health 
system and policy analysts are calling for a move to 
universal health insurance to achieve universal cover-
age.140,141 Other countries with health reforms that parallel 
some aspects of Seguro Popular are Colombia, the 
Dominican Republic, Ghana, Peru, Tanzania, Thailand, 
Turkey, and Vietnam.142–145,146,147
A lesson from the Mexican experience is the importance 
of monitoring and assessment. Evidence has played a 
central role in steering the reform process including the 
revision of enrolment criteria and the deﬁ nition of the 
interventions that have been gradually added to the 
FPCHE. Assessments have also played a crucial part in 
the implementation of accountability mechanisms now 
required by law. Several countries and most notably 
China, have similarly included a strong measurement 
and assessment component in their reforms.147–150 These 
data will provide an opportunity to undertake com-
parative research, especially if rigorous assessment is 
built into reforms with similar indicators of progress 
towards universal health coverage.
The Mexican experience speaks to the potential to 
expand coverage to reach the poor and non-salaried 
workers. It is an example of applying legislative reform to 
use ﬁ nancing from general revenues to cover this 
population, building on existing social and anti poverty 
programmes that enable outreach and enrol ment, such 
as Oportunidades. Indeed, both the reform of IMSS in 
1997 and the 2003 reform that created the Seguro Popular 
increased reliance of the Mexican system on general 
taxation and government revenue to ﬁ nance health.
The Mexican process points to the importance of 
continuity. Good programmes and policies should be 
preserved, enriched, and even expanded across admin-
istrations when these have been proven eﬀ ective based 
on rigorous assessment.151 The technical capacity of 
policy makers helps with this process.
The Mexican experience is especially noteworthy for 
having continued despite and throughout economic 
downturn and periods of economic crisis.152 Seguro 
Popular survived the economic crisis of 2008–09, and 
covered services were continually expanded in the wake 
of the downturn. This was the result of political will and 
commitment to the health of the population. Yet 
continuity is also bound by legislative reform, which is 
another lesson. Had the reform been built on a series of 
programmes, rather than a new law, continuity might 
have been questioned. Another lesson is the importance 
of long-term investment in the development of research 
and educational institutions that generate evidence for 
policy design and implementation. These institutions 
also train leaders to occupy policy-making positions at 
the local and federal levels providing the managerial 
capacity to implement reform.
The Mexican reform shows that, although challenging, 
developing countries can expand ﬁ nancial coverage for 
treatment of chronic diseases. Part of the global 
community has been convinced that middle-income and 
especially low-income countries should limit their 
activities to prevention in the case of chronic and non-
communicable diseases.153,154 The Mexican case shows 
that developing nations can build ﬁ scally responsible 
mechanisms, such as the FPCHE, to ﬁ nance cost-
eﬀ ective treatment for chronic diseases alongside 
prevention.42,155 Fiscally responsible reform implies the 
design and implementation of not only health policies 
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but also healthy policies that deal with social 
determinants.
The creation of a separate and protected fund for public 
goods, and especially community health services and 
personal and non-personal public health inter ventions, is 
another ﬁ nding. This creation oﬀ ers a way to extend other 
services without neglecting, and indeed while expanding, 
health promotion, disease prevention, and early detection 
services. Civil society has also contributed to the process 
of implementing the reform by sharing knowledge and 
encouraging patient involvement, which in turn builds 
responsiveness. Further, civil society provides com-
plementary services for better delivery of care.
The Mexican health system has proﬁ ted from a clear 
deﬁ nition of priorities, which are important not only in 
terms of resource allocation, but also to garner public 
support. Distinctive initiatives of the Mexican reform, 
such as MING and Fair Start in Life, were also used to 
bridge the divide between the vertical and horizontal 
approaches to health care through the development of 
what has been called the diagonal strategy.156 These 
initiatives show that it is possible to use explicit, high-
priority interventions to drive system-wide improvement 
(ie, in quality)134,135 into the overall health system.
Together, the instruments designed and implemented 
in Mexico constitute a map to expand the three 
dimensions of social protection of health: against health 
risks; for patients by assuring safety, eﬀ ectiveness, and 
responsiveness; and against the ﬁ nancial consequences 
of disease.
The Mexican quest for universal health coverage and 
the creation of the System of Social Protection in Health 
through legislative reform encompasses 9 years of well 
documented eﬀ orts to achieve universality. These eﬀ orts 
can be adapted and translated for other countries seeking 
to provide universal coverage against threats to the health 
security of individuals and populations. Learning from 
this experience—both its successes and its challenges—
will not only continue to improve health conditions and 
ﬁ nancial protection for all people in Mexico, but will also 
contribute to the global movement towards universal 
health coverage.
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